Advancing a multi-asset pipeline of high-impact therapeutic solutions

Our pipeline is comprised of innovative therapeutic products that have the potential for optimized value creation using our partnership-enabled business model.

SWIPE TO SCROLL swipe to scroll
Pipeline

Our flagship product candidates, Virtue SAB and BackBeat CNT, exemplify key criteria that characterize innovations optimized for strategic partnerships:

  • Target large therapeutic device markets with significant unmet needs
  • Provide high impact procedure-based solutions with rapid adoption potential
  • Offer strategic and financial benefits to commercial partners

*Minimally Invasive Surgical (MIS) solutions

Virtue® SAB is not approved for commercial use in the US

BackBeat CNT™ is not approved for commercial use in the US
Orchestra BioMed logo

© 2022 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Disclaimer